“Patients infected with P. … and treated with imipenem were more likely to experience clinical failure (OR 4.21, CI 1.51-11.12, I2=…%) and to develop resistance to the study carbapenem (OR 2.86, CI 1.08-6.44, I2= 13%) than those treated with alternative β-lactams.”